Amarin Corp Plc (AMRN)

[couldbebetter]

Zip, The number one mystery with Amarin for me is why no BP
seems to be interested in Vascepa as an adjunct drug for any
& all cancer drugs, treatments, & therapies. Surely Alex Denner
has to be aware of the potential and I would think it would be a
major selling point in attempting a BO. Imagine the potential
benefit that Vascepa cold bring if a company such as Merck adopted
Vascepa for use with Keytruda. My belief is that Vascepa use with
any & all cancer therapies would result in better outcomes for the
patients. Why is this something that is not more widely discussed?
(Perhaps Alex Denner is doing this behind the scenes but does not
want it disclosed for commercial reasons?)